Palliative Resection of a Giant Mesenteric Desmoid Tumor

REFERENCES

1. ↵
   1. Reitamo JJ,
   2. Häyry P,
   3. Nykyri E,
   4. Saxén E.

   (6, 1982) The desmoid tumor. I. Incidence, sex-, age- and anatomical distribution in the Finnish population. Am J Clin Pathol 77(6):665–673, pmid:7091046.

   OpenUrlCrossRefPubMed
2. ↵
   1. Burke AP,
   2. Sobin LH,
   3. Shekitka KM,
   4. Federspiel BH,
   5. Helwig EB.

   (4, 1990) Intra-abdominal fibromatosis. A pathological analysis of 130 tumors with comparison of clinical subgroups. Am J Surg Pathol 14(4):335–341, pmid:2321698.

   OpenUrlCrossRefPubMedWeb of Science
3. ↵
   1. Weiss SW,
   2. Goldblum JR,
   3. Folpe AL

   (2007) Enzinger and Weiss's Soft Tissue Tumors (Elsevier Health Sciences, Philadelphia, PA) eds, 5th ed.
4. ↵
   1. Gurbuz AK,
   2. Giardiello FM,
   3. Petersen GM,
   4. et al.

   (3, 1994) Desmoid tumours in familial adenomatous polyposis. Gut 35:377–381, pmid:8150351, doi: 10.1136/gut.35.3.377.

   OpenUrlAbstract/FREE Full Text
5. ↵
   1. Chaudhary P.

   (12, 2014) Mesenteric fibromatosis. Int J Colorectal Dis 29(12):1445–51, pmid:25139370, doi: 10.1007/s00384-014-1995-7.

   OpenUrlCrossRefPubMed
6. ↵
   1. Lotfi AM,
   2. Dozois RR,
   3. Gordon H,
   4. et al.

   (1989) Mesenteric fibromatosis complicating familial adenomatous polyposis: predisposing factors and results of treatment. Int J Colorectal Dis 4(1):30–36, pmid:2540254.

   OpenUrlCrossRefPubMedWeb of Science
7. ↵
   1. Church JM,
   2. McGannon E,
   3. Ozuner G.

   (5, 1999) The clinical course of intra-abdominal desmoid tumours in patients with familial adenomatous polyposis. Colorectal Dis 1(3):168–173, pmid:23577766, doi: 10.1046/j.1463-1318.1999.00045.x.

   OpenUrlCrossRefPubMed
8. ↵
   1. Lahat G,
   2. Nachmany I,
   3. Itzkowitz E,
   4. et al.

   (7, 2009) Surgery for sporadic abdominal desmoid tumor: is low/no recurrence an achievable goal? Isr Med Assoc J 11(7):398–402, pmid:19911489.

   OpenUrlPubMed
9. ↵
   1. Jones IT,
   2. Jagelman DG,
   3. Fazio VW,
   4. Lavery IC,
   5. Weakley FL,
   6. McGannon E.

   (7, 1986) Desmoid tumors in familial polyposis coli. Ann Surg 204(1):94–97, pmid:3729590.

   OpenUrlPubMedWeb of Science
10. ↵
    1. Tonelli F,
    2. Ficari F,
    3. Valanzano R,
    4. Brandi ML.

    (Jul-Aug 2003) Treatment of desmoids and mesenteric fibromatosis in familial adenomatous polyposis with raloxifene. Tumori 89(4):391–396, pmid:14606641.

    OpenUrlPubMedWeb of Science
11. ↵
    1. Hansmann A,
    2. Adolph C,
    3. Vogel T,
    4. Unger A,
    5. Moeslein G.

    (2 1, 2004) High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors. Cancer 100(3):612–620, pmid:14745880.

    OpenUrlCrossRefPubMedWeb of Science
12. ↵
    1. Penel N,
    2. Le Cesne A,
    3. Bui BN,
    4. et al.

    (2, 2011) Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase II trial with a long-term follow-up. Ann Oncol 22(2):452–457, pmid:20622000, doi: 10.1093/annonc/mdq341.

    OpenUrlCrossRefPubMedWeb of Science
13. ↵
    1. Gronchi A,
    2. Colombo C,
    3. Le Péchoux C,
    4. et al.

    (3, 2014) Sporadic desmoid-type fibromatosis: a stepwise approach to a non-metastasising neoplasm—a position paper from the Italian and the French Sarcoma Group. Ann Oncol 25(3):578–583, pmid:24325833, doi: 10.1093/annonc/mdt485.

    OpenUrlCrossRefPubMedWeb of Science
14. ↵
    1. Spear MA,
    2. Jennings LC,
    3. Mankin HJ,
    4. et al.

    (2 1, 1998) Individualizing management of aggressive fibromatoses. Int J Radiat Oncol Biol Phys 40(3):637–645, pmid:9486614.

    OpenUrlCrossRefPubMedWeb of Science
15. 1. Ballo MT,
    2. Zagars GK,
    3. Pollack A,
    4. Pisters PW,
    5. Pollack RA.

    (1, 1999) Desmoid tumor: prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy. J Clin Oncol 17(1):158–167, pmid:10458229.

    OpenUrlAbstract/FREE Full Text
16. 1. Merchant NB,
    2. Lewis JJ,
    3. Woodruff JM,
    4. Leung DH,
    5. Brennan MF.

    (11 15, 1999) Extremity and trunk desmoid tumors: a multifactorial analysis of outcome. Cancer 86(10):2045–2052, pmid:10570430.

    OpenUrlCrossRefPubMedWeb of Science
17. ↵
    1. Gronchi A,
    2. Casali PG,
    3. Mariani L,
    4. et al.

    (4 1, 2003) Quality of surgery and outcome in extra-abdominal aggressive fibromatosis: a series of patients surgically treated at a single institution. J Clin Oncol 21(7):1390–1397, pmid:12663732.

    OpenUrlAbstract/FREE Full Text
18. ↵
    1. Nuyttens JJ,
    2. Rust PF,
    3. Thomas CR Jr.,
    4. Turrisi AT 3rd.

    (4 1, 2000) Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumors: A comparative review of 22 articles. Cancer 88(7):1517–1523, pmid:10738207.

    OpenUrlCrossRefPubMedWeb of Science
19. ↵
    1. Guadagnolo BA,
    2. Zagars GK,
    3. Ballo MT.

    (6 1, 2008) Long-term outcomes for desmoid tumors treated with radiation therapy. Int J of Radiat Oncol Biol Phys 71(2):441–447, pmid:18068311.

    OpenUrlPubMed
20. ↵
    1. Fiore M,
    2. Rimareix F,
    3. Mariani L,
    4. et al.

    (9, 2009) Desmoid-type fibromatosis: a front-line conservative approach to select patients for surgical treatment. Ann Surg Oncol 16(9):2587–2593, pmid:19568815, doi: 10.1245/s10434-009-0586-2.

    OpenUrlCrossRefPubMedWeb of Science
21. ↵
    1. Garbay D,
    2. Le Cesne A,
    3. Penel N,
    4. et al.

    (1, 2012) Chemotherapy in patients with desmoid tumors: a study from the French Sarcoma Group (FSG). Ann Oncol 23(1):182–186, pmid:21444357, doi: 10.1093/annonc/mdr051.

    OpenUrlCrossRefPubMedWeb of Science